Voyageur Pharmaceuticals to settle $192,300 debt with shares
- Voyageur Pharmaceuticals (VM:CA) proposes to settle $192,300 of debt by issuing common shares at $0.155 per share. $52,300 owed to a company officer for accrued consulting fees will be settled through 337,419 shares.
- The remaining $140,000 owed to other creditors will be settled through 903,225 shares.
- The $0.155 deemed share price equals Voyageur’s September 24, 2026 TSX Venture Exchange closing price.
- The proposed settlement would result in the issuance of 1.24M common shares in total.
More on Voyageur Pharmaceuticals Ltd.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.